EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, InhaleRx's enterprise value is A$5.54 Mil.
InhaleRx's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil. Therefore, InhaleRx's EV-to-Revenue for today is .
The historical rank and industry rank for InhaleRx's EV-to-Revenue or its related term are showing as below:
During the past 7 years, the highest EV-to-Revenue of InhaleRx was 220.53. The lowest was 0.06. And the median was 33.39.
ASX:IRX's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.25 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-05-29), InhaleRx's stock price is A$0.03.
InhaleRx's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00. Therefore, InhaleRx's PS Ratio for today is .
InhaleRx EV-to-Revenue Historical Data
The historical data trend for InhaleRx's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of InhaleRx's EV-to-Revenue
For the Medical Devices subindustry, InhaleRx's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InhaleRx's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InhaleRx's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where InhaleRx's EV-to-Revenue falls into.
InhaleRx's current Enterprise Value is A$5.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. InhaleRx's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InhaleRx's share price for today is A$0.03.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InhaleRx EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of InhaleRx's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:IRX has been successfully added to your 